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SulﬁdeHydrogen sulﬁde is enzymatically produced in mammalian tissues and functions as a gaseous transmitter.
However, H2S is also highly toxic as it inhibits mitochondrial respiration at the level of cytochrome c oxidase,
which additionally is involved in sulﬁde oxidation. The accumulation of toxic sulﬁde levels contributes
to the pathology of some diseases. This paper demonstrates that sulﬁde toxicity can be modiﬁed, and
dehydroascorbic acid functions as an effector in this process. It signiﬁcantly reduces the inhibitory effect
of sulﬁde on cytochrome c oxidase, resulting in higher rates of respiration and sulﬁde oxidation in rat
mitochondria. After the addition of dehydroascorbic acid mitochondria maintained more than 50% of the
oxygen consumption andATP production rateswith different substrates in the presence of high concentrations
of sulﬁde that would normally lead to complete inhibition. Dehydroascorbic acid signiﬁcantly increased the
sulﬁde concentration necessary to cause half maximal inhibition of mitochondrial respiration and thus
completely prevented inhibition at low, physiological sulﬁde concentrations. In addition, sulﬁde oxidation
was stimulated and led to ATP production even at high concentrations. The decrease in sulﬁde toxicity was
more pronounced when analyzing supermolecular functional units of the respiratory chain than in isolated
cytochrome c oxidase activity. Furthermore, the protective effect of dehydroascorbic acid at high sulﬁde
concentrations was completely abolished by quantitative solubilization of mitochondrial membrane proteins
with dodeclymaltoside. These results suggest that binding of cytochrome c oxidase to other proteins probably
within respiratory chain supercomplexes is involved in the modulation of sulﬁde oxidation and toxicity by
dehydroascorbic acid.D, N,N,N′,N′-tetramethyl-p-
nover, Herrenhäuser Straße 2,
x: +49 511 762 3608.
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Hydrogen sulﬁde is a gaseous signalling molecule in mammals
functionally similar to nitric oxide and carbon monoxide [1]. It takes
part in the regulation of blood pressure and insulin secretion by
activating K+ATP channels. Beneﬁcial effects became obvious during
ischemia reperfusion injury, where sulﬁde protects tissues from
apoptosis and inﬂammation [2]. However, sulﬁde is also highly toxic
with exposure to high concentrations leading to apnea [3]. The
pathological accumulation of endogenous sulﬁde can decrease insulin
secretion in diabetes and causes severe neuronal failure as well as
circulatory disorder and chronic diarrhea in ethylmalonic encepha-
lopathy [4,5]. Sulﬁde is produced from cysteine in the cytosol of many
different cell types mainly by two enzymes of the transsulfuration
pathway, cystathionine-β-synthase and cystathionine-γ-lyase. In
some tissues such as the brain reduction of sulfane sulfur that isproduced by β-mercaptopyruvate sulfurtransferase might also
generate considerable amounts of H2S [2]. At cellular pH about 81 %
of the sulﬁde is present as hydrosulﬁde anion (HS-) and 19 % as H2S
gas, which is highly lipophilic and therefore freely diffuses across
membranes [1].
The catabolic pathway catalyzing sulﬁde oxidation to thiosulfate
or sulfate is localized in the mitochondria [6]. The ﬁrst oxidation
step is catalyzed by sulﬁde:quinone oxidoreductase, which is bound
to the inner mitochondrial membrane and transfers electrons to
the ubiquinone pool. The persulﬁdes produced by sulﬁde:quinone
oxidoreductase are further oxidized by a sulfur dioxygenase in the
mitochondrial matrix producing sulﬁte. Sulﬁte can ﬁnally either be
conjugated to a persulﬁde molecule to produce thiosulfate by the
mitochondrial matrix sulfurtransferase rhodanese, or it is transported
into the intermembrane space and oxidized to sulfate by sulﬁte
oxidase, which transfers electrons to cytochrome c. Therefore, two
reactions of the sulﬁde oxidation pathway transfer electrons into
the respiratory chain potentially taking part in ATP production.
Indeed, sulﬁde has been identiﬁed as the ﬁrst inorganic substrate for
mammalian mitochondria [7].
Strikingly, one of the main mechanisms of sulﬁde toxicity is the
strong but reversible inhibition of cytochrome c oxidase [8]. As a
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but it additionally inhibits its own detoxiﬁcation pathway. Increasing
sulﬁde concentrations would thus eventually lead to a complete and
irreversible block of sulﬁde oxidation and aerobic energy production.
The results presented here indicate presence of a regulatorymechanism
that decreases sulﬁde toxicity in mammalian mitochondria so that
respiration and sulﬁde detoxiﬁcation can continue even in the presence
of relatively high sulﬁde concentrations. The mitochondrial metabolite
dehydroascorbic acid, which has recently been found to be involved
in sulﬁde oxidation in the lugworm Arenicola marina [9], functions as
an effector in this process.
2. Materials and methods
2.1. Animals
Livers, kidneys and hearts were taken from adult Sprague Dawley
rats which had been fed ad libitum and were sacriﬁced by carbon
dioxide asphyxiation.
2.2. Chemicals
Sulﬁde stock solutions (50 μM–2 mM)were prepared immediately
before use by dissolving sodium hydrosulﬁde (Sigma-Aldrich,
Taufkirchen, Germany) in deoxygenated distilled water. The sulﬁde
concentrationwas analyzed photometrically using a commercial sulﬁde
test (Spektroquant, Merck, Darmstadt, Germany). Stock solutions of
dehydro-L-(+)-ascorbic acid (Sigma-Aldrich, Taufkirchen, Germany)
were also prepared immediately before use. A colorimetric assay was
used to determine the DHA concentration [10].
2.3. Puriﬁcation procedures
Mitochondria were prepared from rat liver, kidney, brain and heart
as described [6].
2.4. Assay of mitochondrial respiration
Mitochondrial respiration [nmol O2 mg protein−1 min−1] was
measured polarographically in an oxygraph respirometer (Oroboros,
Innsbruck, Austria) at 25 °C. Oxygen consumption was calculated
based on an initial oxygen concentration in air saturated incubation
medium of 221 μM [11]. The reaction mixture (2 ml) contained
mitochondria in incubation medium (250 mM sucrose, 10 mM
triethanolamine, 1 mM EGTA, 2 mM KH2PO4, 2 mM K2HPO4 and
5 mMMgCl2, pH 7.4). Where indicated mitochondria were solubilized
with dodecylmaltoside (1.6 g per g protein) or digitonin (0.5–4 g per g
protein) prior to the experiment. Succinate (4 mM), glutamate
(8 mM) or N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD,
250 μM) plus ascorbate (1 mM) were added as substrates, and ADP
(1 mM) was used to establish state 3 respiration. Respiration was
inhibited by NaHS (5–200 μM) or KCN (15 μM), and the effect of
additional injection of DHA (0.1–2.0 mM) was studied.
2.5. Measurement of ATP production
ATP production [nmol ATP mg protein−1 min−1] was determined
at room temperature by means of a coupled enzyme assay [12]
described in detail by Bagarinao and Vetter [13].
2.6. Measurement of sulﬁde oxidation
Sulﬁde oxidation [μmol l−1min−1] was assayed at 25 °C in
incubation medium. Samples (1 ml) containing 50 μM sulﬁde and
ADP (1 mM)plusDHA (1 mM), succinate (4 mM),myxothiazole (5 μM)
and brain or liver mitochondria (0.4 mg protein ml−1) in differentcombinations were incubated for 5 min. The sulﬁde concentration
was analyzed photometrically using a commercial sulﬁde test based
on methylene blue production (Spektroquant, Merck, Darmstadt,
Germany).
2.7. Enzyme assays
All assays were performed at room temperature in a total volume
of 300 μl using an Epoch microplate spectrophotometer (BioTek
Instruments, Winooski, USA). Mitochondria were permeabilized by
freezing and thawing in 25 mM potassium phosphate buffer pH 7.4,
which was also used for the activity assays. Cytochrome c oxidase
activity was measured as the oxidation rate of reduced cytochrome c
(15 μM, ε=19.1 mM−1cm−1 at 550 nm) [14]. Reduced cytochrome
c was prepared by addition of sodium dithionite with subsequent
separation by Sephadex G25 chromatography and stored at−80 °C.
The activity of the functional unit of complex III plus complex
IV was determined by monitoring the enzymatic oxidation
rate of decylubiquinole at 275 nm (100 μM, ε=15 mM−1cm−1).
Decylubiquinone was dissolved in ethanol and reduced as described
[15]. The oxidation rate of NADH (0.2 mM, ε=6.3 mM−1cm−1 at
340 nm) in the absence of an external electron acceptor was used to
quantify the activity of the functional unit consisting of complex I
plus complex III plus complex IV. All rates were corrected for NADH
oxidation by reactions independent of the respiratory chain such as
matrix dehydrogenases (1.7 nmol NADH mg protein−1min−1),
which was measured in the presence of myxothiazole.
2.8. Gel electrophoresis procedure
Mitochondrial membrane proteins (0.5 mg) were separated by
blue-native PAGE on 4.5–12.6% gradient gels as described [16].
Dodecylmaltoside (1.6 g/g) and digitonin (4 g/g) were used as
detergents [17]. Cytochrome c oxidase was detected via activity
staining [18].
2.9. Data analysis
Data are given as means±standard deviation of the results from
3–6 experiments. Signiﬁcant differences between means were
evaluated by t-tests at the pb0.05 level using a statistical software
package (SigmaPlot 11.0, Systat Software, Erkrath, Germany). Values
for maximal inhibition (Imax) and the sulﬁde concentration at half
maximal inhibition (IC50) were also calculated in SigmaPlot 11.0 by
non-linear least-square analysis of the data using a hyperbolic ﬁt.
3. Results
3.1. DHA decreases the inhibitory effect of sulﬁde on mitochondrial
respiration
The respiration rate of the rat liver mitochondria used for this
study with succinate added as a substrate was 67.5±4.0 nmol O2mg
protein−1min−1 in state 3 with a respiratory control ratio of 4.3±
0.7. It was completely inhibited by 50 μM NaHS and 10 μM NaHS
decreased respiration rates by 75±7 % (Fig. 1). However, when
dehydroascorbic acid (DHA), the oxidized form of vitamin C, was
added to themitochondrial suspension, oxygen consumption continued
in the presence of 50 and even 200 μM NaHS with a residual activity
of about 40 nmol O2mg protein−1min−1. This residual oxygen con-
sumption was sensitive towards myxothiazole, an inhibitor of complex
III (Fig. 1A). Thus, it truly representedmitochondrial respiration andwas
not caused by a different oxygen dependent reaction. 1 mM DHA
decreased the maximal inhibition of succinate respiration by sulﬁde
to 59±6% and increased the sulﬁde concentration necessary to
cause half maximal inhibition (IC50) more than 20fold from 2.8±0.6
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Fig. 1. Dehydroascorbic acid decreases the inhibitory effect of sulﬁde on succinate respiration in rat liver mitochondria. (A) Oxygen consumption trace of a typical experiment
containing 0.25 mg/ml mitochondrial protein. Additions were 4 mM succinate, 1 mM ADP, 50 μM sulﬁde (NaHS), 1 mM dehydroascorbic acid (DHA) and 5 μM myxothiazol.
(B) Inhibition [%] of succinate respiration in rat liver mitochondria by different sulﬁde concentrations (5–200 μM) before (●) and after (□) the addition of 1 mM DHA. Data points
represent means from 3 experiments. Solid lines: hyperbolic ﬁt; IC50: sulﬁde concentration at half maximal inhibition; Imax: percentage of maximal inhibition.
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and DHA were similar (38.4±7.1 nmol O2mg protein−1min−1) when
glutamate,which transfers electrons to complex I,wasusedas a substrate
(Supplementary material, Fig. 1). However, as state 3 respiration was
lower with glutamate (25.9±3.6 nmol O2mg protein−1min−1)
than with succinate, inhibition values were negative, indicating that
electrons from sulﬁde oxidation also contributed to the total rate of
oxygen consumption.
The protective effect of DHA was not restricted to liver. Succinate
respiration in heart, kidney and brain mitochondria was inhibited
almost completely by 50 μM NaHS, but only by 42±4% in kidney
and by 34±15% in heart in the presence of 1 mM DHA. In brain
mitochondria succinate respiration was even fully restored after the
addition of DHA (Fig. 2).
The degree of protection depended on sulﬁde as well as on DHA
concentrations (Fig. 3). Low concentrations of DHA (≤0.1 mM) were
sufﬁcient to restore full succinate respiration in liver mitochondria
in the presence of low concentrations of NaHS. With higher sulﬁde
concentrations (50 μM) only partial protection was achieved and
higher concentrations of DHA (0.5−1 mM) were necessary for the
maximal effect.
DHA alone had no observable effect onmitochondrial respiration in
the concentration range tested (0.1–2 mM), and the order of injection
was irrelevant for theﬁnal rate of oxygen consumption in the presence
of sulﬁde and DHA. Also, the reduced form of vitamin C, ascorbic acid
(5 mM), did not inﬂuence sulﬁde toxicity in mitochondria. The
protective effect of DHA was unaltered, when ascorbate (5 mM) and
DHA (0.5 mM) were added simultaneously to mimic physiological
conditions (data not shown).R
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Fig. 2. Dehydroascorbic acid decreases the inhibitory effect of sulﬁde on succinate
respiration in rat kidney, heart and brain mitochondria. State 3 respiration (black bars)
was inhibited by the addition of 50 μMNaHS (white bars) and subsequently 1 mMDHA
was injected (grey bars).DHA not only restored oxygen consumption but also enabled
mitochondria to maintain about 80 % of their ATP production rate in
the presence of 50 μM sulﬁde, which otherwise completely blocked
ATP production (Fig. 4).
In order to ﬁnd out, whether the decrease of toxicity was speciﬁc
to sulﬁde or also observable with other inhibitors of cytochrome c
oxidase, the inﬂuence of DHA on cyanide inhibited respiration was
tested. Oxygen consumption of liver mitochondria using succinate as
a substrate was inhibited by 52.6±0.7% after the addition of 15 μM
KCN. DHA (1 mM) signiﬁcantly decreased inhibition to 38.8±2.4%
(data not shown).
3.2. DHA increases rates of mitochondrial sulﬁde oxidation
The effect of DHA on the metabolism of sulﬁde was studied by
analyzing rates of sulﬁde consumption, oxygen consumption and ATP
production in rat liver mitochondria. As a control, sulﬁde oxidation
was measured in brain mitochondria, which have been shown to lack
oxygen dependent sulﬁde oxidizing activity [19], and in incubation
medium without mitochondria. High concentrations of NaHS (50 μM)
were oxidized very slowly with enzymatic oxidation rates not
signiﬁcantly higher than those of the chemical reaction, and no ATP
production was detectable (Figs. 4, 5). Addition of 1 mM DHA
immediately increased oxygen consumption in liver mitochondria but
not in the blank and only slightly in brain mitochondria (Fig. 5A).
However, rates of sulﬁde removal were increased in all DHA containing
samples including controls without mitochondria and mitochondria
that had been inhibited by myxothiazole to block enzymatic sulﬁdeDHA concentration [mM]
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Fig. 3. The protective effect of dehydroascorbic acid against sulﬁde inhibition is
concentration dependent. Succinate respiration of rat liver mitochondria was inhibited
by sulﬁde (□ 10 μM NaHS; ● 50 μM NaHS) and partially restored after the addition of
different DHA concentrations. Respiration rates are given in % of succinate respiration
before sulﬁde addition.
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Fig. 4. ATP production of rat liver mitochondria in the presence of succinate, sulﬁde and
dehydroascorbic acid (DHA). ATP production [nmol/mg protein/min] was determined
photometrically by means of a coupled enzyme assay [12]. Succinate (4 mM) and
NaHS (50 μM) were added as substrates and the effect of DHA (1 mM) on sulﬁde
inhibition was studied. *Signiﬁcantly different (PN0.05) from corresponding data
points without DHA.
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were also stimulated by DHA (Fig. 5B). In liver mitochondria the sulﬁde
oxidation rate was signiﬁcantly higher in samples without inhibitor
than in the presence ofmyxothiazole, showing that sulﬁdewasused as a
respiratory substrate. In contrast, addition of myxothiazole had no
inﬂuence on sulﬁde removal in blanks and brainmitochondria (Fig. 5B).
In accordance with these results, liver mitochondria were able to use
even high concentrations of NaHS as a substrate for ATP production in
the presence of DHA (Fig. 4).
3.3. Possible role of supercomplexes
When directly measuring the activity of cytochrome c oxidase
via the oxidation rate of added cytochrome c, the protective effect
of DHA against inhibition by NaHS was less pronounced than during
mitochondrial respiration (Fig. 6A). The IC50 was increased from
0.64±0.08 to 1.92±0.18 μM NaHS but complete inhibition was still
achieved by about 20 μM NaHS in the presence of 1 mM DHA.
Similar results were obtained when studying the functional entity
of complex III plus complex IV by adding reduced ubiquinone as
a substrate with no external electron acceptor, so that electrons
had to be transferred to oxygen (Fig. 6B; IC50=0.22±0.03 μM NaHS
without DHA and 1.65±0.29 μM NaHS with 1 mM DHA). Only
NADH oxidase activity was protected from inhibition by sulﬁde afterB
sulfide DHA
blank
2 min
2
A
brain
liver
Fig. 5. Dehydroascorbic acid stimulates sulﬁde oxidation. (A) Oxygen consumption traces o
mitochondria. Additions were 50 μM sulﬁde (NaHS) and 1 mM dehydroascorbic acid (DHA).
min] by dehydroascorbic acid. NaHS (50 μM) was added to samples containing rat liver or
concentration was detected after 5 min (white bars). Further samples additionally contain
myxothiazole (grey bars). *Signiﬁcantly different (PN0.05) from corresponding data pointsDHA addition in a similar way as succinate respiration (Fig. 6C).
Maximal inhibition of NADH oxidation by NaHS was decreased from
98.6±2.0% to 85.6±2.3% after the addition of 1 mM DHA and the
IC50 was increased from 0.60±0.07 to 4.93±0.49 μM NaHS. As no
electron acceptor was added, the NADH oxidation rate reﬂects the
concerted activity of respiratory chain complexes I, III and IV. The
additional effect of DHA that was only detectable in this functional
unit of the three individual enzymes, i.e. the partial preservation
of cytochrome c oxidase activity at high sulﬁde concentrations,
was abolished by solubilization of respiratory chain supercomplexes
(Fig. 7).
The different properties of the detergents used for this study
are visible after electrophoretic separation of the samples via blue-
native PAGE (Fig. 7A). Dodecylmaltoside dissolved the protein
complexes from the mitochondrial membrane and disrupted non-
covalent interactions between the individual complexes of the
respiratory chain so that cytochrome c oxidase activity was only
present in the monomer. In contrast, the milder detergent digitonin
conserved a number of supermolecular associations called super-
complexes, some of them containing cytochrome c oxidase activity.
Respiration of the solubilized mitochondria could be measured by
using TMPD/ascorbate as a substrate, which transfers electrons to
cytochrome c, and oxygen consumption rates were not signiﬁcantly
different from the untreated mitochondria (data not shown). In intact
rat liver mitochondria respiration was decreased from 36.9±7.2
to 2.6±3.9 nmol O2mg protein−1min−1 by 50 μM NaHS, and
after the addition of 1 mM DHA it returned to 43% of the original
rate (15.5±1.3 nmol O2mg protein−1 min−1, Fig. 7B). The protective
effect was completely abolished in mitochondria solubilized with
dodecylmaltoside. In contrast, when digitonin was used as a detergent
inhibition by sulﬁde was still signiﬁcantly reduced to 82±2% in
the presence of DHA. However, the effect was much less pronounced
than in intact mitochondria, and therefore the inﬂuence of digitonin
concentration was tested.
Mitochondria were incubated with increasing concentrations
of digitonin (0.5–4 g/g) and respiration was measured before and
after the addition of sulﬁde (50 μM) and DHA (1 mM) (Fig. 7C). For
this experiment succinate was chosen as a substrate because it allows
monitoring the solubilization of structures necessary to sustain
electron transport and the effect of DHA in the same experiment.
Succinate respiration was decreased by more than 50% in mitochon-
dria treated with 1 g/g digitonin, indicating that the inner mitochon-
drial membrane was affected and electron transport from complex II
to cytochrome c oxidase became less efﬁcient. However, a major part
of the residual activity was insensitive to sulﬁde inhibition in the
presence of DHA, which is comparable to the situation in intact
mitochondria. The structure conveying this protective effect partially0
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Fig. 6. Inhibition [%] of different functional units of the respiratory chain by NaHS in the presence (□) and in the absence (●) of 1 mMdehydroascorbic acid. (A) Complex IV activity of
rat livermitochondriawasmeasured as the oxidation rate of reduced cytochrome c. Activitywithout inhibitionwas 346±76 nmol cytochrome c mg protein−1min−1. (B) Complexes
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maximal inhibition increased to about 80%.
4. Discussion
Hydrogen sulﬁde from different sources, mainly from endogenous
production and of microbial origin in the gut, is constantly present
in themammalian body. The oxidation of sulﬁde has been shown to be
a priority of mammalian cells, and the severe consequences of a
breakdownof the pathwaynecessary for sulﬁde detoxiﬁcation become
obvious in the fatal disease ethylmalonic encephalophathy [5,19].
However, it is difﬁcult to estimate the physiological concentration of
sulﬁde in different tissues due to methodical constraints, and reports
in the literature range from nanomolar to high micromolar concen-
trations (see [1] for discussion). As isolated cytochrome c oxidase
activity is strongly inhibited by sulﬁde at concentrations lower than
1 μM, this aspect has to be considered physiologically relevant even
under healthy conditions [20]. Interestingly, respiration of isolated
mitochondria or whole cells is signiﬁcantly less susceptible and not
affected by sulﬁde concentrations up to 5–20 μM [19,21, this study].
At least partially this discrepancy can be explained by an efﬁcient0
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which rapidly lowers the ambient concentration. Moreover, other
cellular factorsmight be present in vivo to control the binding of sulﬁde
to cytochrome c oxidase.
Dehydroascorbic acid is a good candidate for such modifying factor
because it has been shown to affect sulﬁde oxidation in the sulﬁde
adapted invertebrate Arenicola marina [9], and it is readily available in
mammalian mitochondria. Ascorbic acid, the main form of vitamin c
in cells, functions as a reductant during the biosynthesis of collagen,
carnitine and catecholamine thereby producing DHA [22]. Rat and
mouse liver contains about 3 mM ascorbic acid [23,24], but it is difﬁcult
to determine the physiological DHA concentration because it is rapidly
recycled to ascorbic acid by enzymatic and non-enzymatic reduction.
A fraction of 5–7 % DHA has been estimated for plasma [25]. However,
DHAconcentrations canbemarkedly increasedunder certain conditions
involving oxidative stress such as inﬂammation or ischemia reperfusion
injury [22]. Especially in mitochondria local gradients might occur
with a transient increase of DHA in regions of high ROS production at
the respiratory chain, where ascorbic acid acts as a major antioxidant.
Furthermore, ascorbic acid transport into mitochondria mainly takes
place in form of DHA via the glucose transporter GLUT1 [26].DDM
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The results presented here demonstrate that DHA is able to
completely prevent inhibition of cytochrome c oxidase at low sulﬁde
concentrations, which are certainly relevant for mitochondria in the
physiological context. As a consequence, mitochondria maintain their
regular energy metabolism including ATP production in the presence
of this potent inhibitor of the respiratory chain. Partial protection is
provided even at relatively high sulﬁde concentrations that might
occur locally or temporarily.
The easiest explanation for the decrease of sulﬁde toxicity in the
presence of DHA would be a direct interaction of the two compounds.
Very high concentrations of sulﬁde, i.e. a solution saturated with
H2S gas, can be used as a reductant to quantitatively convert DHA
to ascorbate [27]. Rates of non-enzymatic sulﬁde consumption
also increased after the addition of DHA under the experimental
conditions used in this study. Therefore, a decrease of the free sulﬁde
concentration by binding to DHA and chemical oxidation is certainly
part of the story. But it is not sufﬁcient to explain all results. If the
effect was exclusively chemical it could be expected to be indepen-
dent of the assay system used to determine cytochrome c oxidase
activity. Nevertheless respiration with different substrates such as
succinate, NADH and TMPD continued in the presence of 50 μM
sulﬁde plus 1 mM DHA whereas the oxidation of externally added
cytochrome c was already completely inhibited at lower sulﬁde
concentrations. Therefore, an additional mechanism probably exists
that prevents binding of sulﬁde to cytochrome c oxidase either by
decreasing the afﬁnity or via steric protection of the active site of
the enzyme. This effect is independent of membrane potential, as
it was not abolished by freezing and thawing of the mitochondria
(data not shown).
4.2. Hypothetical mechanism of the decrease in sulﬁde toxicity by DHA
In order to deduce a valid mechanistic model for the protective
effect of DHA, it is important to consider the exact mechanism of
cytochrome c oxidase inhibition by sulﬁde. The inhibition kinetics are
rather complex, and the current model predicts the binding of two
sulﬁde molecules to the binuclear centre, at reduced CuB and oxidized
heme a3 respectively [28]. This mechanism of inhibition occurs
immediately after the addition of sulﬁde, requires only nanomolar
concentrations, and is fully reversible [20]. Chronic exposure to
higher sulﬁde concentrations (0.1–0.5 mM) induces an additional,
irreversible level of cytochrome c oxidase inhibition that is caused
by structural destabilization and accelerated degradation of speciﬁc
subunits [29]. However, these long-term modiﬁcations are not
relevant for the present study, which exclusively deals with
immediate effects of sulﬁde on isolated mitochondria.
A modulator of sulﬁde toxicity such as DHA could function via
allosteric modiﬁcation of sulﬁde afﬁnity to the active site of
cytochrome c oxidase. The sulﬁde afﬁnity of protein bound heme
groups depends on the position of certain proximate amino acid
residues, as has been demonstrated for a bacterial truncated
hemoglobin specialized on sulﬁde binding [30]. Therefore, confor-
mational changes of cytochrome c oxidase subunits leading to
a slight shift of amino acid residues at heme a3 could weaken the
Fe3+–SH−-bond. It has already been demonstrated that cytochrome
c oxidase is regulated allosterically by phosphorylation of speciﬁc
subunits [31]. Inhibition by cyanide was also partially reversed in the
presence of DHA, indicating that binding of similar inhibitors to
cytochrome c oxidase can be modulated by a common mechanism.
However, the molecular interaction of the different inhibitors
with the active site is not identical, and therefore the inﬂuence
of DHA is likely to be differently pronounced [8]. As the protective
effect of DHA was not observable in isolated cytochrome c oxidase
activity, the underlying mechanism probably involves interactionswith additional proteins. Oligomeric association sometimes is a
prerequisite for allosteric modulation like in haemoglobin, where
binding of 2,3-bisphosphoglycerate at the interface between mono-
mers decreases the oxygen afﬁnity [32]. Similarly, the mechanism
of DHA regulation could be based on binding of the effector at the
interface of cytochrome c oxidase and an additional protein that is
part of a larger complex. The binding of DHA would then lead to a
conformational change that decreases sulﬁde afﬁnity to cytochrome c
oxidase. Such an effect can be expected to be speciﬁc for DHA and
not inducible by the structurally related reduced form ascorbic acid,
which is in accordance with the experimental data.
4.3. Possible role of supercomplexes
Cytochrome c oxidase is part of several functional associations
within the respiratory chain termed supercomplexes. Stable and
speciﬁc interactions with complex I and III in different stoichiometries
(III2IV1–2, I1III2IV1–4) have been repeatedly demonstrated by mild
membrane solubilization and BN-PAGE [33,34]. In most experiments
succinate dehydrogenase was not found to be part of a supercomplex.
However, about a ﬁfth of the oxygen consumption rate with succinate
added as a substrate was still present in rat liver mitochondria after
solubilization with 4 g/g digitonin, which is routinely used to isolate
respiratory supercomplexes [this study, 17,35]. As electron transport
via free ubiquinone and cytochrome c pools is unlikely after
solubilization of the inner mitochondrial membrane, at least some
of the complex II molecules seem to be able to functionally interact
with complex III and IV. These results are in line with the recent
identiﬁcation of complete respirasomes consisting of the respiratory
chain complexes I, II, III and IV with tightly bound ubiquinone and
cytochrome c. These supercomplexes are fully functional and catalyze
electron transport from NADH or succinate to oxygen [17]. The
present results indicate that they might be involved in the
modiﬁcation of inhibitor binding to cytochrome c oxidase. The
strongest decrease in sulﬁde toxicity via DHA was detectable in intact
mitochondria with substrates that transfer electrons to either
complex I or II of the respiratory chain. Oxygen consumption in this
assay represents the sum of respiration and sulﬁde oxidation, i.e.
electrons from both the carbon substrate and sulﬁde contribute to
the total rate. Mammalian mitochondria have been shown to even
favour sulﬁde over complex I substrates in order to prevent the
accumulation of toxic sulﬁde concentrations [19]. Therefore, residual
NADH oxidase activity in the presence of sulﬁde and DHA can be
expected to be lower than total respiration, which is supported by the
data. However, the protective effect of DHA was not detectable when
electron transmitters that normally function within the respirasome
(ubiquinone or cytochrome c) were added externally, so obviously
the access of these molecules was limited in the particular kind of
supercomplex with decreased sulﬁde afﬁnity (Fig. 8A). It was
completely abolished by quantitative solubilization of the individual
respiratory chain complexes with dodecylmaltoside [17,35]. In
contrast, a fraction of the protective effect was conserved after
treatment with digitonin, which is the mildest detergent available
[35]. These results conﬁrm that binding of cytochrome c oxidase to
other proteins is essential for the decrease in sulﬁde toxicity by
DHA. However, digitonin titration revealed a sharp drop in succinate
respiration in the presence of sulﬁde and DHA between 1 and 2 g
detergent per g protein. Obviously the structure conveying maximal
protection is not stable at the digitonin concentrations that are used
for the isolation of respiratory chain supercomplexes. The currently
available methods are still insufﬁcient to detect all interactions
present in vivo. There are hints that in intact mitochondria individual
supercomplexes might be arranged in even larger respiratory strings
or patches, and ATP synthase dimers form ribbons along the apex of
cristae membranes [36–38]. Probably several additional proteins
are able to interact with cytochrome c oxidase, and some examples
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Fig. 8. Hypothetical role of dehydroascorbic acid in mitochondrial respiration and sulﬁde oxidation: DHA decreases the inhibitory effect of sulﬁde on cytochrome c oxidase (complex
IV) via allosteric effects only when it is part of a supermolecular functional unit. A: NADH, succinate and TMPD can be oxidized by a respirasome consisting of respiratory chain
complexes I-IV. Association with additional proteins (green) is probably involved in the modiﬁcation of sulﬁde binding to cytochrome c oxidase by DHA. B: Sulﬁde is oxidized to
either sulfate or thiosulfate in three steps via persulﬁde and sulﬁte. Electrons are transferred into the respiratory chain possibly by a supercomplex that is specialized on sulﬁde
oxidation, containing sulﬁde:quinone oxidoreductase and sulﬁte oxidase. I, II, III, IV: respiratory chain complexes; c: cytochrome c; Q: ubiquinone; SQR: sulﬁde:quinone
oxidoreductase; SDO: sulfur dioxygenase; ST: sulfur transferase; SO: sulﬁte oxidase; dashed lines: electron transport in the respiratory chain.
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synthase, and large-conductance Ca2+-activated K+ channel have
already been identiﬁed by immunoprecipitation [39–41]. The data
presented here suggest that at least one of these presently unknown
interactions is part of the mechanism that modulates sulﬁde toxicity
in mitochondria.
DHA not only decreases the inhibitory effect of sulﬁde on respiration
but also increases rates of sulﬁde oxidation. Therefore, sulﬁde:quinone
oxidoreductase and sulﬁte oxidase, the twomembrane bound enzymes
of the pathway catalyzing sulﬁde oxidation, which transfer electrons
into the respiratory chain, might also be associated to a supercomplex
in vivo (Fig. 8B). So far, there are no reports in the literature about
supercomplexes specialized on sulﬁde oxidation, but, if present, they
are probably of low abundance and perhaps the protein interactions
are also less stable during solubilization.
4.4. Physiological relevance
Obviously the rapid oxidation to non-toxic compounds is impor-
tant for an efﬁcient detoxiﬁcation of exogenous as well as endogenous
sulﬁde. Especially in the liver this pathway is involved in the
degradation of the sulfur containing amino acids methionine and
cysteine [42]. DHA also decreases sulﬁde toxicity in mitochondria
from other tissues that have been shown to oxidize sulﬁde
enzymatically such as kidney and heart [19]. As a consequence,
sulﬁde can be used as an inorganic substrate for ATP production in a
wide concentration range, but this aspect is presumably of limited
importance compared to the normal organic substrates. In contrast to
most tissues, brain mitochondria probably lack at least part of the
sulﬁde oxidizing pathway and are therefore more sensitive to sulﬁde
poisoning [19]. The present data support this ﬁnding as even in the
presence of DHA no enzymatic sulﬁde oxidation was detectable.
However, the protective effect of DHA was most pronounced in the
brain demonstrating that this mechanism is particularly important
in the absence of an efﬁcient sulﬁde detoxiﬁcation pathway.
The modiﬁcation of sulﬁde removal could play a critical role in
sulﬁde signalling as a means to determine the ambient concentration
and lifetime of the gaseous messenger. DHA is more suitable to be a
regulatory molecule than the main functionally active form of vitamin
C, ascorbic acid, because its concentration is lower and more ﬂexible.
The fraction of oxidized vitamin C reﬂects the redox state of the cellor organelle and can therefore induce a speciﬁc modiﬁcation of sulﬁde
metabolism. For example during ischemia reperfusion events mito-
chondrial dysfunction is a major cause of cell death and inﬂammation.
The inhibition of respiration by sulﬁde is thought to be cytoprotective
primarily during the initial phase of reperfusion as it decreases the
production of reactive oxygen species [43]. Subsequently residual ROS
formation might produce DHA, which reduces the inhibitory effect of
sulﬁde and allows mitochondria to return to normal respiration.
4.5. Therapeutic potential
The identiﬁcation of DHA as an instrument to reduce sulﬁde toxicity
may become clinically relevant during the treatment of sulﬁde
poisoning either after accidental environmental exposure or in patients
that accumulate endogenous sulﬁde, e.g. in ethylmalonic encephalop-
athy. This directed ampliﬁcation of sulﬁde oxidation rates could be an
alternative therapeutic approach to the inhibition of sulﬁde producing
enzymes, which is already being tested [44]. Maximal intracellular
concentrationsof vitaminC (3–4 mM)are achievedby supplementation
of 200 mg ascorbic acid per day [45]. For acute treatment it is also
possible to administer DHA directly via intravenous injection, which
raises intracellular ascorbate concentrations to supraphysiological
levels and thus probably provides enough DHA to be protective against
sulﬁde toxicity [46].
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbabio.2011.06.003.
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